Search results
Laurie Hollis Glimcher (born 1951) is an American physician-scientist who was appointed president and CEO of Dana–Farber Cancer Institute in October 2016. She was elected a Member of the American Philosophical Society in 2019.
- 3; including Jake Auchincloss
Laurie H. Glimcher, MD is the President and CEO of Dana-Farber Cancer Institute, Director of the Dana-Farber/Harvard Cancer Center, and the Richard and Susan Smith Professor of Medicine at Harvard Medical School.
Laurie H. Glimcher, MD, is the President and CEO of Dana-Farber Cancer Institute, Director of the Dana-Farber/Harvard Cancer Center, and the Richard and Susan Smith Professor of Medicine at Harvard Medical School.
Laurie H. Glimcher, MD, is the President and CEO of the Dana-Farber Cancer Institute, Director of the Dana-Farber/Harvard Cancer Center, and the Richard and Susan Smith Professor of Medicine at Harvard Medical School.
Feb 27, 2024 · Glimcher is hardly the first Dana-Farber executive to recognize growing tensions between her institution and the Brigham as well as its parent company Mass General Brigham over the future of cancer care in Boston. But she is the first to confront the issue head-on.
The findings, compiled by a British molecular biologist Sholto David, revealed deliberate fabrications by researchers in the labs of Dana-Farber’s chief executive, Dr. Laurie Glimcher, and its chief operating officer, Dr. William Hahn.
Jun 18, 2022 · Laurie H. Glimcher, MD, president and CEO of Dana-Farber Cancer Institute is among the 2022 class of Modern Healthcare’s 50 Most Influential Clinical Executives award.
